Css LLC Apellis Pharmaceuticals, Inc. Call Options Transaction History

Css LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $304,368 - $473,688	6,800 New	6,800 $464,000
Q2 2022 Aug 15, 2022	SELL	$35.07 - $59.21 $1.35 Million - $2.28 Million	-38,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$35.46 - $54.12 $1.37 Million - $2.08 Million	38,500 New	38,500 $1.96 Million
Q2 2020 Aug 14, 2020	SELL	$24.8 - $38.49 $173,600 - $269,430	-7,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $17,910 - $44,330	-1,000 Reduced 12.5%	7,000 $188,000
Q4 2019 Feb 14, 2020	BUY	$22.1 - $30.8 $176,800 - $246,400	8,000 New	8,000 $245,000

309

115M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.6B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.